Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 132C (TMEM132C) is a predicted multi-pass membrane protein belonging to the TMEM132 family, which is conserved in vertebrates and shares domain architecture with other family members including extracellular cohesin and Ig-like domains[3]. TMEM132C is classified within the protein phosphatase 1 regulatory subunit family (PPP1R), but its precise molecular function remains to be elucidated. In situ hybridization studies in mouse embryonic tissues show that TMEM132C is expressed in regions such as the dorsal midbrain, somites, surface ectoderm, and certain parts of the cochlea; this suggests potential roles in nervous system and inner ear development[3]. While the TMEM132 family as a whole is associated with some human genetic disorders (mainly neurological) and possibly with cancer, there are currently no drugs targeting TMEM132C and its direct physiological roles or disease associations are largely unknown[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 132C (TMEM132C).